Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal
- KO Validated
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal COX2 / Cyclooxygenase 2 antibody. N-terminal. Suitable for IP, WB, ICC/IF and reacts with Mouse, Human samples. Cited in 7 publications.
View Alternative Names
COX2, PTGS2, Prostaglandin G/H synthase 2, Cyclooxygenase-2, PHS II, Prostaglandin H2 synthase 2, Prostaglandin-endoperoxide synthase 2, COX-2, PGH synthase 2, PGHS-2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (AB188183)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) cells, untreated or treated with lipopolysaccharide (1 μg/ml) for 6 hours, labeling COX2 / Cyclooxygenase 2 with ab188183 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing increased cytoplasmic staining on RAW 264.7 cells treated with lipopolysaccharide (1 μg/ml) for 6 hours.
The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (AB188183)
COX2 / Cyclooxygenase 2 was immunoprecipitated from 0.35 mg of NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate with ab188183 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab188183 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : NIH/3T3 whole cell lysate 10μg (Input).
Lane 2 : ab188183 IP in NIH/3T3 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab188183 in NIH/3T3 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure : 3 minutes.
All lanes:
Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (ab188183)
Predicted band size: 69 kDa
Observed band size: 74 kDa
false
- WB
Lab
Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (AB188183)
False colour image of Western blot : Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab188183 was shown to bind specifically to COX2 / Cyclooxygenase 2. A band was observed at 74-76 kDa in wild-type A549 cell lysates with no signal observed at this size in PTGS2 knockout cell line ab280802 (knockout cell lysate ab283825). Band at 70 kDa in both wild-type and knockout samples is non-specific but exact protein is not determined. To generate this image, wild-type and PTGS2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (ab188183) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
PTGS2 knockout A549 cell lysate at 20 µg
Lane 3:
U-87 MG cell lysate at 20 µg
Lane 4:
MOLT-4 cell lysate at 20 µg
Observed band size: 74-76 kDa
false
- WB
Supplier Data
Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (AB188183)
Exposure time : Lane 1 : 8 seconds; Lane 2 : 2 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (ab188183) at 1/1000 dilution
Lane 1:
A549 (human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 69 kDa
Observed band size: 74 kDa
true
- WB
Supplier Data
Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (AB188183)
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile and molecular weight observed is consistent with what has been described in the literature (PMID : 9737714). COX2 protein expression is induced by LPS in neutrophils.
All lanes:
Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - N-terminal (ab188183) at 1/1000 dilution
Lane 1:
Untreated RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 20 µg
Lane 2:
RAW 264.7 treated with 1 μg/ml LPS for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 69 kDa
Observed band size: 74 kDa
true
Exposure time: 1s
Related conjugates and formulations (1)
-
Anti-COX2 / Cyclooxygenase 2 antibody [EPR18377-106] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
COX2 plays a significant role in the inflammatory response and is part of the complex process of synthesizing prostaglandins. These compounds mediate inflammation and pain making COX2 an important target for understanding these processes. COX2 is not ubiquitously expressed but rather is induced in activated macrophages and other cells during inflammatory conditions. Its function is also important for normal physiological processes like ovulation and implantation.
Pathways
COX2 is essential in the prostaglandin biosynthesis pathway connecting it to the arachidonic acid metabolism pathway. Cyclooxygenase 2 works with phospholipase A2 which releases arachidonic acid from the phospholipid membrane. COX2 then converts this acid to prostaglandin H2 a precursor for other prostaglandins. COX1 the other isoform of cyclooxygenase is closely related to COX2 and while they have different expression patterns they share some functional similarities in these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Science advances 11:eadq2881 PubMed40009679
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37108248
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:952950 PubMed36238561
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 21:618-629 PubMed35073820
2022
Applications
Unspecified application
Species
Unspecified reactive species
ACS nano 16:50-67 PubMed34873906
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:825 PubMed34149871
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 17:4611-4618 PubMed29328454
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com